New York Stem Cell Foundation Inc
- Assets
- $76.0m
- Revenue
- $43.6m
- Investments
- $0.0
- Employees
- 138
- Location
- New York, NY
- Founding
- 07/2005
- Data as of
- 06/2021
- EIN
- 20-2905531
Organization Overview
New York Stem Cell Foundation Inc is located in New York, NY. The organization was established in 2005. According to its NTEE Classification (H20) the organization is classified as: Birth Defects & Genetic Diseases Research, under the broad grouping of Medical Research and related organizations. As of 06/2021, New York Stem Cell Foundation Inc employed 138 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. New York Stem Cell Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2021, New York Stem Cell Foundation Inc generated $43.6m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 7.0% each year. All expenses for the organization totaled $39.7m during the year ending 06/2021. While expenses have increased by 9.8% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, New York Stem Cell Foundation Inc has awarded 120 individual grants totaling $40,388,001. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
SEE SCHEDULE O.TO ADVANCE THE MOST CUTTING-EDGE STEM CELL RESEARCH IN THE WORLD, TO SUPPORT STEM CELL SCIENTISTS, AND TO EDUCATE THE PUBLIC.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SEE SCHEDULE O
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Susan L Solomon CEO & Director | OfficerTrustee | 40 | $764,222 |
Jeffrey Wallerstein Chief Financial & Operating Officer | Officer | 40 | $456,581 |
Elizabeth Schwarzbach Chief Business Officer | 40 | $347,993 | |
Daniel Paull Vice Pres., Stem Cell Tech. Platform | 40 | $305,830 | |
Christine Lin Chief Advancement Officer | 40 | $274,426 | |
Frederick Monsma Senior Vp, Scientific Operations | 40 | $273,143 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Dla Piper Llp Legal | 6/29/21 | $446,425 |
Britton Business Computing It Consultant | 6/29/21 | $166,969 |
Kevin Eggan Co Nyscf Consultant | 6/29/21 | $108,329 |
Validation Masters Engineering Consultant | 6/29/21 | $128,513 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $1,529,429 |
| Related organizations | $0 |
| Government grants | $2,491,800 |
| All other contributions, gifts, grants, and similar amounts not included above | $37,677,589 |
| Noncash contributions included in lines 1a–1f | $29,666 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $41,698,818 |
| Total Program Service Revenue | $0 |
| Investment income | $1,715 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $353,032 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $43,590,530 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $7,604,411 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $1,800,000 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,374,375 |
| Compensation of current officers, directors, key employees. | $339,398 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $10,639,467 |
| Pension plan accruals and contributions | $451,459 |
| Other employee benefits | $1,380,559 |
| Payroll taxes | $876,469 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $860,315 |
| Fees for services: Accounting | $36,846 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $558,236 |
| Advertising and promotion | $0 |
| Office expenses | $558,092 |
| Information technology | $203,748 |
| Royalties | $0 |
| Occupancy | $4,347,916 |
| Travel | $6,445 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $97,077 |
| Interest | $344,844 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $2,504,038 |
| Insurance | $282,230 |
| All other expenses | $15,539 |
| Total functional expenses | $39,653,628 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $526 |
| Savings and temporary cash investments | $5,624,737 |
| Pledges and grants receivable | $43,519,741 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $579,850 |
| Net Land, buildings, and equipment | $25,356,986 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $868,174 |
| Total assets | $75,950,014 |
| Accounts payable and accrued expenses | $2,230,399 |
| Grants payable | $650,903 |
| Deferred revenue | $925,275 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $7,824,634 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $12,743,940 |
| Total liabilities | $24,375,151 |
| Net assets without donor restrictions | $7,070,289 |
| Net assets with donor restrictions | $44,504,574 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $75,950,014 |
Grants Awarded
Over the last fiscal year, New York Stem Cell Foundation Inc has awarded $7,625,810 in support to 21 organizations.
| Grant Recipient | Amount |
|---|---|
Redwood City, CA PURPOSE: GRANT | $1,200,000 |
Boston, MA PURPOSE: GRANT | $900,000 |
Princeton, NJ PURPOSE: GRANT | $600,000 |
UNIVERSITY OF CALIFORNIA BERKELEY PURPOSE: GRANT | $600,000 |
Seattle, WA PURPOSE: GRANT | $600,000 |
Cambridge, MA PURPOSE: GRANT | $600,000 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that New York Stem Cell Foundation Inc has recieved totaling $25,000.
| Awarding Organization | Amount |
|---|---|
Gray Foundation Cohoes, NY PURPOSE: TO FURTHER THE EXEMPT PURPOSE OF THE ORGANIZATION. | $25,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Philadelphia Fight Philadelphia, PA | $17,499,427 | $51,561,885 |
Cardiovascular Research Foundation New York, NY | $57,426,030 | $52,277,749 |
New York Stem Cell Foundation Inc New York, NY | $75,950,014 | $43,590,530 |
The National Hemophilia Foundation New York, NY | $46,786,068 | $26,439,522 |
The Foundation For Embryonic Competence Inc Basking Ridge, NJ | $27,223,706 | $15,272,541 |
Hauptman-Woodward Medical Research Institute Inc Buffalo, NY | $26,101,769 | $9,359,091 |
Fshd Society Randolph, MA | $6,079,315 | $3,508,920 |
Hearing Health Foundation New York, NY | $12,344,240 | $5,730,095 |
Center For Human Genetics Inc Cambridge, MA | $9,835,244 | $2,410,975 |
Hereditary Disease Foundation New York, NY | $15,507,063 | $4,059,819 |
Cerebral Palsy Alliance Research Foundation New York, NY | $1,906,191 | $2,233,194 |
Research Fund For Cystic Fibrosis Inc Oradell, NJ | $1,621,345 | $155,788 |